Pacira BioSciences, Inc.
PCRX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $7.80M | $3.86M |
| Net Income | -$11.89M | -$9.78M |
| EPS Diluted | -$0.47 | -$0.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR